Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First in Human Phase 1 Open-Label, Multicenter, Dose Escalation and Expansion Study of DEG6498 in Patients With Solid Tumors

NCT07244835 is registered in ClinicalTrials.gov with Degron Therapeutics Co. as lead sponsor.

NCT NCT07244835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07244835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First in Human Phase 1 Open-Label, Multicenter, Dose Escalation and Expansion Study of DEG6498 in Patients With Solid Tumors
Lead sponsor
Degron Therapeutics Co.
Phase
Phase 1
Overall status
Recruiting
Start date
November 13, 2025
Completion date
December 31, 2028
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasms